The 2021 Annual
PRIMO Meeting Agenda
The PRIMO meeting Co-Chairs and Steering Committee worked hard to curate an agenda to meet the educational needs of all attendees and focused on the following key areas:
- Practical considerations of applying biomarkers and targeted therapy
- Integration of immunotherapy, with a focus on novel management approaches
- Patient selection, as well as timing and sequencing of therapy
- Dealing with important trends, such as big data and defining value in cancer care
NOTE: All times listed are in Central Standard Time (CST)
Wednesday, Febuary 10th, 2021
Hematologic Malignancies - Julie Vose / Sagar Lonial
Product Theater
4:20 PM – 5:20 PM
Product Theater (Non-CME/CE)
Hematologic Malignancies (cont.)
5:20 PM – 5:40 PM
CLL: What is the Best Initial Therapy for a Newly Diagnosed patient?
6:00 PM – 6:20 PM
Break I Visit the Virtual Exhibits
Gastrointestinal Malignancies – Rachna T. Shroff
Product Theater
7:20 PM – 8:20 PM
Product Theater (Non-CME/CE)
Closing Remarks
Thursday, Febuary 11th, 2021
Melanoma, Skin Cancers, RCC – Shane Morita
4:00 PM – 4:20 PM
Medical Therapy for Head and Neck Cancers: Current Status
Product Theater
4:20 PM – 5:20 PM
Product Theater (Non-CME/CE)
GU Cancers - Sanjiv Agarwala
6:20 PM – 6:40 PM
Break I Visit the Virtual Exhibits
Lung - Paul A. Bunn
Product Theater
7:40 PM – 8:40 PM
Product Theater (Non-CME/CE)
Closing Remarks
Friday, Febuary 12th, 2021
Breast Cancer – Hope S. RugoHope S. Rugo, MD
Product Theater
4:20 PM – 5:20 PM
Product Theater (Non-CME/CE)
Breast Cancer (CONT.)
5:20 PM – 5:40 PM
Managing the Toxicity of Endocrine Therapy: Diet, Exercise, Sexual Health
Hope S. Rugo, MD
6:20 PM – 6:40 PM
SITC on Practical Recommendations Including Reimbursement Issues for Immunotherapy
6:40 PM – 7:00 PM
Break | Visit the Virtual Exhibits
Other Women’s Cancers
Closing Remarks